PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions

• Published in: Cancer gene therapy Vol. 31; no. 2; pp. 322 - 333
• Main Authors: Pan, Yi-Ru, Lai, Joseph Chieh-Yu, Huang, Wen-Kuan, Peng, Pei-Hua, Jung, Shih-Ming, Lin, Sheng-Hsuan, Chen, Chiao-Ping, Wu, Chiao-En, Hung, Tsai-Hsien, Yu, Alice L., Wu, Kou-Juey, Yeh, Chun-Nan
• Format: Journal Article
• Language: English
• Published: New York Nature Publishing Group US 01-02-2024; Nature Publishing Group
• Subjects: 13; 14; 38; 45; 631/67/1059/602; 64/60; 692/699/67; 82; 96; Adherens junctions; Biomedical and Life Sciences; Biomedicine; Cell cycle; Cell junctions; Cell proliferation; Cholangiocarcinoma; Chromatin; Dimerization; E-cadherin; Gene Expression; Gene Therapy; Medical prognosis; Mortality; Motility; Myosin; Polo-like kinase 1; Transcriptomes; Transposase; Tumorigenesis; Wound healing
• ISSN: 0929-1903; 1476-5500
• DOI: 10.1038/s41417-023-00705-z

Intrahepatic cholangiocarcinoma (iCCA) is a subtype of CCA and has a high mortality rate and a relatively poor prognosis. However, studies focusing on increased cell motility and loss of epithelial integrity during iCCA progression remain relatively scarce. We collected seven fresh tumor samples from four patients to perform RNA sequencing (RNA-seq) and assay for transposase-accessible chromatin using sequencing (ATAC-seq) to determine the transcriptome profile and chromatin accessibility of iCCA. The increased expression of cell cycle regulators, including PLK1 and its substrate MISP, was identified. Ninety-one iCCA patients were used to validate the clinical significance of PLK1 and MISP. The upregulation of PLK1 and MISP was determined in iCCA tissues. Increased expression of PLK1 and MISP was significantly correlated with tumor number, N stage, and lymphatic invasion in an iCCA cohort. Knockdown of PLK1 or MISP reduced trans-lymphatic endothelial migration and wound healing and affected focal adhesions in vitro. In cell‒cell junctions, MISP localized to adherens junctions and suppressed E-cadherin dimerization. PLK1 disrupted adherens junctions in a myosin-dependent manner. Furthermore, PLK1 and MISP promoted cell proliferation in vitro and tumorigenesis in vivo. In iCCA, PLK1 and MISP promote aggressiveness by increasing lymphatic invasion, tumor growth, and motility through the repression of E-cadherin adherens junctions.